Show simple item record

dc.contributor.authorThiemermann, Cen_US
dc.date.accessioned2016-05-26T11:37:11Z
dc.date.issued2007en_US
dc.date.submitted2016-05-25T14:25:38.102Z
dc.identifier.issn1466-609Xen_US
dc.identifier.other10.1186/cc5912
dc.identifier.other132
dc.identifier.other132en_US
dc.identifier.other132en_US
dc.identifier.other132en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/12541
dc.description.sponsorshipWilliam Harvey Research Foundationen_US
dc.format.extent? - ?en_US
dc.language.isoenen_US
dc.relation.ispartofCRIT CAREen_US
dc.rightsCC0 1.0 Universal
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/
dc.subjectRECOMBINANT-HUMAN-ERYTHROPOIETINen_US
dc.subjectISCHEMIA-REPERFUSIONen_US
dc.subjectINJURYen_US
dc.subjectPROTECTSen_US
dc.subjectDISEASEen_US
dc.titleBeneficial effects of erythropoietin in preclinical models of shock and organ failureen_US
dc.typeArticle
dc.rights.holder07 BioMed Central Ltd
dc.identifier.doi10.1186/cc5912en_US
pubs.issue3en_US
pubs.notesNot knownen_US
pubs.volume11en_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC0 1.0 Universal
Except where otherwise noted, this item's license is described as CC0 1.0 Universal